Arylsulfatase B of human lung. Isolation, characterization, and interaction with slow-reacting substance of anaphylaxis

The Journal of Clinical Investigation
S I Wasserman, K F Austen

Abstract

Arylsulfatase B was separated from arylsulfatase A in extracts of human lung tissue by anion exchange chromatography and further purified by gel filtration and cation exchange chromatography. Arylsulfatase B of human lung was similar to that enzyme in other tissues and species, exhibiting an apparent mol wt of approximately 60,000, a pH optimum for cleavage of 4-nitrocatechol sulfate (pNCS) of 5.5-6.0, and a sensitivity to inhibition by phosphate ions and especially pyrophosphate in the presence of NaCl. Human lung arylsulfatase B inactivated slow-reacting substance of anaphylaxix (SRS-A) in a linear time-dependent reaction in which the rate was determined by the enzyme-to-substrate ratio. Cleavage of pNCS by human lung arylsulfatase B was competitively suppressed by SRS-A. The finding that human lung tissue contains predominately arylsulfatase B discloses a potential regulatory mechanism for inactivation of SRS-A at or near the site of its generation.

References

Oct 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·E J Goetzl, K F Austen
Aug 9, 1973·The New England Journal of Medicine·M KalinerK F Austen
Nov 1, 1974·The Journal of Experimental Medicine·R A LewisK F Austen
Jul 12, 1973·Biochimica Et Biophysica Acta·W S Bleszynski, A B Roy
Feb 1, 1974·Proceedings of the Society for Experimental Biology and Medicine·C H YangW L Williams
Jan 13, 1971·Biochimica Et Biophysica Acta·A B Roy
Jan 1, 1980·Biochimica Et Biophysica Acta·C I Prosser, A B Roy
May 1, 1959·Clinica Chimica Acta; International Journal of Clinical Chemistry·H BAUMB SPENCER
Apr 1, 1962·Archives of Biochemistry and Biophysics·B WORTMAN

Citations

Jun 1, 1981·Springer Seminars in Immunopathology·B U Wintroub, N A Soter
Nov 1, 1980·The Journal of Allergy and Clinical Immunology·N A Soter, S I Wasserman
Jan 1, 1980·International Journal of Immunopharmacology·P Sirois, P Borgeat
Oct 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·J HouglumC J Sih
Jan 1, 1983·The Journal of Clinical Investigation·P F Weller, K F Austen
Mar 23, 2013·PloS One·Myungsik YooMelitta Schachner
Sep 1, 1981·Journal of Periodontology·R C Page, H E Schroeder
Aug 5, 2009·Experimental Dermatology·Matthew L RenningerHarm Hogenesch
Oct 8, 2004·Journal of Biochemistry and Molecular Biology·Mahmoud BalbaaKamal Kandeel
Jun 30, 1986·Toxicology and Applied Pharmacology·D J Guth, R D Mavis
Oct 1, 1981·Australian and New Zealand Journal of Medicine·J P Seale
Dec 1, 1992·FEMS Microbiology Immunology·L M Stevenson, D G Jones
Nov 28, 1981·The Medical Journal of Australia·J P Seale

Related Concepts

Chondro-4-Sulfatase
Chromatography
Molecular Sieve Chromatography
Drug Interactions
Eosinophil
Hydrogen-Ion Concentration
Lung
SRS-A
Sulfatases

Related Feeds

Anaphylaxis

Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death.